RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

公众评估报告 公众评估报告 (PAR)
27-11-2017

有效成分:

raloxifene hydrochloride, Quantity: 60 mg

可用日期:

MedTAS Pty Ltd

INN(国际名称):

Raloxifene hydrochloride

药物剂型:

Tablet, film coated

组成:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

给药途径:

Oral

每包单位数:

28 tablets

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

產品總結:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

授权状态:

Licence status A

授权日期:

2014-01-14